Literature DB >> 21877740

Charybdotoxin unbinding from the mKv1.3 potassium channel: a combined computational and experimental study.

Morteza Khabiri1, Azadeh Nikouee, Lukasz Cwiklik, Stephan Grissmer, Rüdiger Ettrich.   

Abstract

Charybdotoxin, belonging to the group of so-called scorpion toxins, is a short peptide able to block many voltage-gated potassium channels, such as mKv1.3, with high affinity. We use a reliable homology model based on the high-resolution crystal structure of the 94% sequence identical homologue Kv1.2 for charybdotoxin docking followed by molecular dynamics simulations to investigate the mechanism and energetics of unbinding, tracing the behavior of the channel protein and charybdotoxin during umbrella-sampling simulations as charybdotoxin is moved away from the binding site. The potential of mean force is constructed from the umbrella sampling simulations and combined with K(d) and free energy values gained experimentally using the patch-clamp technique to study the free energy of binding at different ion concentrations and the mechanism of the charybdotoxin-mKv1.3 binding process. A possible charybdotoxin binding mechanism is deduced that includes an initial hydrophobic contact followed by stepwise electrostatic interactions and finally optimization of hydrogen bonds and salt bridges.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21877740     DOI: 10.1021/jp2061909

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  13 in total

1.  Scorpion toxins prefer salt solutions.

Authors:  Azadeh Nikouee; Morteza Khabiri; Lukasz Cwiklik
Journal:  J Mol Model       Date:  2015-10-16       Impact factor: 1.810

Review 2.  Computational methods of studying the binding of toxins from venomous animals to biological ion channels: theory and applications.

Authors:  Dan Gordon; Rong Chen; Shin-Ho Chung
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 3.  Computational approaches for designing potent and selective analogs of peptide toxins as novel therapeutics.

Authors:  Serdar Kuyucak; Raymond S Norton
Journal:  Future Med Chem       Date:  2014-10       Impact factor: 3.808

4.  Olfactory bulb-targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice.

Authors:  Austin B Schwartz; Anshika Kapur; Zhenbo Huang; Raveendra Anangi; John M Spear; Scott Stagg; Erminia Fardone; Zolan Dekan; Jens T Rosenberg; Samuel C Grant; Glenn F King; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2020-10-20       Impact factor: 5.372

5.  Molecular dynamics simulations of scorpion toxin recognition by the Ca(2+)-activated potassium channel KCa3.1.

Authors:  Rong Chen; Shin-Ho Chung
Journal:  Biophys J       Date:  2013-10-15       Impact factor: 4.033

6.  Structural basis of the selective block of Kv1.2 by maurotoxin from computer simulations.

Authors:  Rong Chen; Shin-Ho Chung
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

Review 7.  Computational Studies of Venom Peptides Targeting Potassium Channels.

Authors:  Rong Chen; Shin-Ho Chung
Journal:  Toxins (Basel)       Date:  2015-12-01       Impact factor: 4.546

Review 8.  Computational studies of marine toxins targeting ion channels.

Authors:  M Harunur Rashid; Somayeh Mahdavi; Serdar Kuyucak
Journal:  Mar Drugs       Date:  2013-03-13       Impact factor: 5.118

9.  Electrophysiological characterization of Ts6 and Ts7, K⁺ channel toxins isolated through an improved Tityus serrulatus venom purification procedure.

Authors:  Felipe A Cerni; Manuela B Pucca; Steve Peigneur; Caroline M Cremonez; Karla C F Bordon; Jan Tytgat; Eliane C Arantes
Journal:  Toxins (Basel)       Date:  2014-02-28       Impact factor: 4.546

10.  Binding modes of two scorpion toxins to the voltage-gated potassium channel kv1.3 revealed from molecular dynamics.

Authors:  Rong Chen; Shin-Ho Chung
Journal:  Toxins (Basel)       Date:  2014-07-22       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.